Nested-PCR based Detection of Hepatitis C Virus: Low-cost Strategy in Pakistan: Nested-PCR based detection of Hepatitis C virus

Rabia Javeed; Nabeela Tariq; Shakeela Daud; Asma Yousafzai; Saba Manzoor; Adeel Ahmad

doi:10.53560/PPASB(59-3)709

Authors

Rabia Javeed Department of Zoology, Sardar Bahadar Khan Women University, Quetta, Balochistan, Pakistan
Nabeela Tariq Department of Zoology, Sardar Bahadar Khan Women University, Quetta, Balochistan, Pakistan
Shakeela Daud Department of Biotechnology, Balochistan University of Information Technology, Engineering and Management Sciences, Quetta, Balochistan, Pakistan
Asma Yousafzai Department of Biotechnology, Balochistan University of Information Technology, Engineering and Management Sciences, Quetta, Balochistan, Pakistan
Saba Manzoor Institute of Biochemistry and Biotechnology, University of Veterinary & Animal Sciences, Lahore, Pakistan
Adeel Ahmad Continental Medical College and Hayat Memorial Hospital Lahore, Pakistan

DOI:

https://doi.org/10.53560/PPASB(59-3)709

Keywords:

Hepatitis C, Comparison Diagnostic Test, Polymerase Chain Reaction

Abstract

One of the most common blood-borne illnesses is hepatitis C virus (HCV), Hepatitis C is referred to as the inflammation of the liver and caused by the HCV virus, HCV is estimated to cause 53000 fatalities per year over the world. The majority of HCV-infected patients are unaware of their infection. No vaccine is available for HCV although Interferon is used to treat HCV but effective only 20-38 %, but at present, only a minority of infected persons have been tested and are aware of their diagnosis. The expense of testing may play a substantial role in patients' ability to get rid of the hepatitis C virus (HCV). Costs in many low- and middle-income nations, including Pakistan, force the development of novel and economically advantageous testing methods. The major aim of this study is about the effective diagnostic procedure for detecting Hepatitis C in the samples obtained from Balochistan, for this purpose the samples were collected from the health organization BINUQ (Balochistan Institute of Nephrology and Urology Quetta). Twenty (20) HCV antibodies positive patients in the Molecular Laboratory Department of Biotechnology were processed and then subjected to RNA extraction. cDNA was synthesized by reverse transcriptase enzyme. cDNA was used for qualitative analysis of HCV-RNA through nested PCR. According to the study, 09 samples were detected as positive and 7 samples were HCV negative out of 16 patients’ samples. The findings of the present study show comparison of the price for HCV- RNA tests per sample from patients with hepatitis C at various labs. When compared to the other five PCR-based tests in the laboratory-conducted anti-HCV, HCV qualitative, quantitative, and genotyping tests, Shoukat Khanum laboratory reported the most expensive costs for HCV -RNA tests. Dow laboratory HCV-RNA test is comparatively lower than Shoukat Khanum laboratory, while reported lowest and most cost-effective test of Molecular Diagnostic laboratory for anti-HCV. So, our molecular tests for HCV- RNA detection and quantitation showed very good diagnostic and clinical performance over all five public health laboratories.

References

S.M. Afzal. Hepatitis C virus and interferon-free antiviral therapeutics revolution: implications for Pakistan. Viral Immunology 30:252–257 ( 2017).

M. Hellard, S.E .Schroeder, A. Pedrana, J. Doyle, and C.Aitken . The Elimination of Hepatitis C as a Public Health Threat. Cold Spring Harb perspectives in medicine 1:10(4) (2020)

R.H Miller, and R.H. Purcell. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as embers

of two plant virus supergroups. Proceedings of the National Academy of Sciences of the United States of America 87:2057-61(2012).

M.N. Kamal, and M.H. El-Shabrawi.Burden of pediatric hepatitis C. Asian Journal of Transfusion Science 8(1): 19–25(2014).

N. Bhupinder, M.D. Bhandari, L. Teresa, and M.D.Wright. hepatitis C: An Overview 1995 Annual Review of Medicine 309-317(1995).

A. Bosan, H. Qureshi, K.M. Bile, I. Ahmad, and R. Hafiz. A review of hepatitis viral infections in Pakistan. Journal of the Pakistan Medical

Association 60(12):1045–1058 (2010).

E.S. Rosenberg, E.M. Rosenthal, E.W. Hall, L.Barker, M.G. Hofmeister, P.S.Sullivan, P. Dietz, J. Mermin, and A.B. Ryerson. Prevalence of hepatitis C virus infection in US states and the District of Columbia, 2013 to 2016. JAMA Network Open 1(8): e186371-e186371 (2018).

A. Sohail, A.N. Jamal, and H. Andrew. The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic

review and meta-analysis. BMC Public Health 20:587 (2020).

M.H. El-Shabrawi, and M.N. Kamal. Burden of pediatric hepatitis C. Asian Journal of Transfusion Science 8(1): 19–25 (2014).

A. Kane, Transmission of Hepatitis B, Hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: modelbased regional estimates. World Health Organization 77:801-807 (2010).

WHO. Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. World Health Organization (2016). https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ (accessed Jan 21, 2020)

C.S. Graham, and T. Swan. A path to eradication of hepatitis C in low- andmiddle-income countries. 86 Javeed et al Antiviral Research 119: 89–96 (2015).

E. Stephen-Victor, H. Fickenscher, and J. Bayry. IL26: An Emerging Proinflammatory Member of the IL-10 Cytokine Family with Multifaceted Actions in Antiviral, Antimicrobial, and Autoimmune Responses. PLoS Pathogens 12(6): (2016).

Z. Chen, and K.E. Weck. Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b. Journal of Clinical Microbiology 40(9):3127–3134 (2002).

S, Hamid, M. Umar, A. Alam, A. Siddiqui, H. Qureshi, and J. Butt. PSG consensus statement on management of hepatitis C virus infection--2003. Journal of Pakistan Medical Association 54:146–150 (2004).

H.H. Hsu, and H.B. Greenberg. Hepatitis C. In: P.D. Hoeprich, M.C. Jordan, A.R. Ronald, eds. Infectious Diseases. A treatise of infectious processes, 5th ed. J.B. Lippincott Company. Philadelphia 820-825 (2012).

A.O. Shakil, C. Conry-Cantilena, H.J. Alter, P. Hayashi, D.E. Kleiner, V. Tedeschi, K. Krawczynski, H.S. Conjeevaram, R. Sallie, and A.M. Di Bisceglie. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Annals of Internal Medicine 123:330-7(1995).

L. Blohm, C. Puttmann, S. Holz, G. Piechotta, J. Albers, C. Dammers, M. Kleines, A. Kurten, G. Melmer, J. Nahring, S. Barth, and E. Nebling. Rapid detection of different human anti-HCV immunoglobulins on electrical biochips. Antibody Technology Journal 4:23-32. (2014).

C. Morishima, M. Chung, K.W. Ng, D.J. Brambilla, and D.R. Gretch. Strengths and limitations of commercial tests for hepatitis C virus RNA quantification. Journal of Clinical Microbiology 42: 421–425 (2004).

J.P. Getchell, K.E. Wroblewsk, A. DeMaria Jr, C.L. Bean, M.M. Parker, M. Pandori, D.R. Dufour, M.P. Busch, M.E. Brecher, W.A Meyer, and R.L. Pesano. Testing for HCV infection: an update of guidance for clinicians and laboratorians. Morbidity and Mortality Weekly Report 62(18): 362 (2013)

Y. Mo, R. Wan, and Q. Zhang. Application of Reverse Transcription-PCR and Real-Time PCR in Nanotoxicity Research. Methods in Molecular Biology 926: 99–112 (2012).

D.G Murphy, B.Willems, M. Deschenes, N. Hilzenrat, R. Mousseau, and S. Sabbah. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. Journal of Clinical Microbiology 45(4):1102-1112 (2007).

H.D.J. Daniel, P. Abraham, S. Raghuraman, P. Vivekanandan, T. Subramaniam, and G. Sridharan. Evaluation of a Rapid Assay as an Alternative to Conventional Enzyme Immunoassays for Detection of Hepatitis C Virus-Specific Antibodies. Journal of Clinical Microbiology 43: 1977–1978 (2005).

R. Firdaus, K. Saha, and P.C. Sadhukhan. Rapid immunoassay alone is insufficient for the detection of hepatitis C virus infection among high-risk population. Journal of Viral Hepatitis 20: 290–293 (2013)

Nested-PCR based Detection of Hepatitis C Virus: Low-cost Strategy in Pakistan